Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Electromed (ELMD) Short-Term Debt issuances (2010 - 2013)

Electromed (ELMD) reported Short-Term Debt issuances of -$560000.0 for Q2 2013, down 1300.0% on a QoQ basis from -$40000.0 in Q1 2013.

Electromed (ELMD) has 2 years of Short-Term Debt issuances data on file, last reported at -$560000.0 in Q2 2013.

  • Quarterly Short-Term Debt issuances changed N/A year-over-year to -$560000.0 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was -$600000.0 (changed N/A YoY) and the FY2013 annual result came in at -$1.8 million, changed N/A from the prior year.
  • Short-Term Debt issuances fell to -$560000.0 in Q2 2013 per ELMD's latest filing, from -$40000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at -$40000.0 in Q1 2013 and bottomed at -$560000.0 in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 31.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 37.80 Mn
10 Electromed 300.53 Mn 283.55 Mn 14.64 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2013 -560,000.00
Jun 30, 2013 -560,000.00
Mar 31, 2013 -40,000.00
Mar 31, 2013 -40,000.00
Sep 30, 2010 -500,000.00
Sep 30, 2010 -500,000.00